Clinical commentary on “Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica”

Abstract

Keywords

Neuromyelitis optica (NMO)anaphylactic shock methylprednisolone multiple sclerosis

Get full access to this article

View all access options for this article.

References

Yamasaki

Matsushita

Fukazawa

et al . Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2016; 22(10): 1337–1348.

Trebst

Jarius

Berthele

et al . Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2013; 261(1): 1–16.

La Mantia

Eoli

Milanese

et al . Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol 1994; 34(4): 199–203.

Mehrotra

Saxena

Jaffery

et al . Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol 2007; 55(5): 355–359.

Sadra

Khabbazi

Kolahi

et al . Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: A preliminary study. Int J Rheum Dis 2014; 17(4): 389–393.

Klein-Gitelman

Pachman

Intravenous corticosteroids: Adverse reactions are more variable than expected in children. J Rheumatol 2018; 25(10): 1995–2002.

Vatti

Ali

Teuber

et al . Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol 2013; 47(1): 26–37.